glp-1 weight loss doctors bentonville Availability for Comparing Weight-Loss Surgery and Medications

Fredrick, F., Aggarwal, K., Reddy Meda, A

Patient-level considerations Clinicians considering GLP-1 RAs for patients with suboptimally controlled hypertension should be mindful of existing antihypertensive therapy

Two GLP-1s (Saxenda and Wegovy) are currently approved for use in adolescents ages 12 and up

Hu, Y., Zhu, H., Chen, X., Zhao, B

For example, a starter dose of Novo's Ozempic is 0.25 milligrams

Subscribe to the daily blog at ConscienHealth ( an organization that works with experts and other groups to promote evidence-based approaches to health and obesity and serve as a voice for individuals affected by obesity